Boston University Biomedical Engineering's Avatar

Boston University Biomedical Engineering

@bu-bme.bsky.social

Biomedical Engineering at Boston University. Creating better health for the world since 1969.

31 Followers  |  18 Following  |  2 Posts  |  Joined: 07.04.2025  |  1.261

Latest posts by bu-bme.bsky.social on Bluesky

Post image

With an award from the Hartwell Foundation, BU's Samagya Banskota and colleagues are working on a novel method of developing treatments for β€œrare” genetic diseases that, taken together, affect millions of people.
www.bu.edu/eng/2025/06/...

17.06.2025 14:20 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

A BU team has begun to disentangle cognitive and motor processes, with implications in the near term for the research community and in the long term for people with neurological conditions.
www.bu.edu/eng/2025/06/...

04.06.2025 18:17 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Medical Research Funding β€” Unbreaking How the administration is breaking the government, and what that means for all of us.

I urge everyone to read Unbreaking’s new page on everything the govt is doing to destroy & diminish medical research funding.

It’s the best thing I’ve read on this topic: @lizneeley.bsky.social & co have such done an incredible job.

unbreaking.org/issues/medic...

30.05.2025 21:38 β€” πŸ‘ 1308    πŸ” 807    πŸ’¬ 28    πŸ“Œ 32
Preview
Meet John Ngo, Winner of the 2025 ACS Synthetic Biology Young Innovator Award | ACS Publications Chemistry Blog Read an exclusive interview with Prof. Ngo covering his research, his history with the journal, and advice to early career researchers.

Honored to be the 2025 recipient of the ACS Synthetic Biology Young Innovator Award. Hope to see you in Houston for #SEED2025!

30.04.2025 17:16 β€” πŸ‘ 25    πŸ” 3    πŸ’¬ 2    πŸ“Œ 0
Preview
Standardized droplet preamplification method for downstream circulating cell-free DNA analysis Circulating cell-free DNA (ccfDNA) can be found in blood and other biofluids and is a minimally invasive biomarker for several pathological processes. As tumors become more invasive, an increasing ...

I’m thrilled that the *first* Pratt Lab paper is now out in BioTechniques! This work builds on our published MED-Amp assay, which improves ctDNA detection from low-input (<10 ng/mL) plasma by ~40% compared to targeted NGS and conventional ddPCR. (1/8)

doi.org/10.1080/0736...

23.05.2025 19:20 β€” πŸ‘ 27    πŸ” 3    πŸ’¬ 4    πŸ“Œ 1

@bu-bme is following 18 prominent accounts